BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BlueRock Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11117
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company’s therapeutic candidate is used to treat Parkinson’s disease that restores dopamine production in the midbrain by retaining dopamine-secreting cells which are affected due to degenerative disease conditions. It also develops cardiomyocytes which are lost during the heart attack in an infarcted heart to remuscularize the heart. BlueRock Therapeutics’ therapeutic platform is based on induced pluripotent stem cells which can be generated from cells in a normal blood draw from a consenting adult and produced using cell manufacturing technologies. The company has operations in Canada and the US. BlueRock Therapeutics is headquartered in Toronto, Ontario, Canada.

BlueRock Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
Partnerships 11
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
Licensing Agreements 12
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
Equity Offering 14
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics – Key Competitors 15
BlueRock Therapeutics – Key Employees 16
BlueRock Therapeutics – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Oct 26, 2017: BlueRock Therapeutics Establishes Corporate Headquarters in Cambridge, Massachusetts and Bolsters Team to Support Rapid Growth and Development 18
Aug 17, 2017: BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership 19
Corporate Communications 20
Sep 20, 2018: BlueRock Therapeutics names Shane Kovacs as chief business and financial officer 20
Dec 01, 2017: BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior VP, Manufacturing, Quality and Regulatory 21
Jun 27, 2017: BlueRock Therapeutics Announces Key Members of Executive Team 22
Government and Public Interest 23
Jan 05, 2018: Get to Know the Revolutionary Medical Innovations Being Unleashed in Canada 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics, Key Competitors 15
BlueRock Therapeutics, Key Employees 16
BlueRock Therapeutics, Other Locations 17

List of Figures
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Heineken NV:企業のM&A・事業提携・投資動向
    Heineken NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heineken NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TC BioPharm Ltd (TC BioPharm) is an immunotherapy company that develops cell based products for treatment of cancer and viral infection. The company pipeline products are intended for the treatment of ovarian cancer, breast cancer and epidermolysisbullosa related disease, among others. It wo …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務情報
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IBIDEN CO., LTD.:企業の戦略・SWOT・財務分析
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mutual Trust Bank Limited:企業の戦略・SWOT・財務情報
    Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Arise AB (ARISE)-エネルギー分野:企業M&A・提携分析
    Summary Arise AB (Arise) is an independent onshore wind company. It has a presence in the entire value chain from prospecting and permit management to financing, construction, sale, and long-term management of its own and others’ wind farms. The company owns wind plants in southern Sweden; and co-ow …
  • Tetraphase Pharmaceuticals Inc (TTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases cau …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lee’s Pharmaceutical Holdings Ltd (950):製薬・医療:M&Aディール及び事業提携情報
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • Checkpoint Therapeutics Inc (CKPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes non-chemotherapy and immune enhanced combination treatments for the treatment of solid tumor cancers. The comp …
  • Electricidade de Mocambique EP-エネルギー分野:企業M&A・提携分析
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. The company produces electricity from hydro and thermal sources. It has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Banco Santander-Chile:企業の戦略・SWOT・財務分析
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ontario Teachers’ Pension Plan:戦略・SWOT・企業財務分析
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cosmo Films Ltd:戦略・SWOT・企業財務分析
    Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆